Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Nirenberg

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 31, 2024
BAUSSS biomarker improves melanoma survival risk assessmentAnthony J Dixon, Howard K Steinman, Alexander Nirenberg, et al.
Journal of Clinical Medicine|March 28, 2024
Primary Cutaneous Melanoma-Management in 2024Anthony Joseph Dixon, Michael Sladden, Christos C Zouboulis, et al.
Journal of Clinical Medicine|January 11, 2025
Reply to Pennington, T.E.; Thompson, J.F. Sentinel Node Biopsy in Melanoma Remains a Valuable Clinical Tool. Comment on "Dixon et al. Primary Cutaneous Melanoma-Management in 2024. <i>J. Clin. Med.</i> 2024, <i>13</i>, 1607"Anthony Joseph Dixon, Michael Sladden, Christos C Zouboulis, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 20, 2024
BAUSSS biomarker further validated as a key risk staging tool for patients with primary melanomaAnthony J Dixon, Athanassios Kyrgidis, Michael Sladden, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 23, 2024
Sentinel lymph node biopsy may no longer be a critical component of melanoma managementAthanassios Kyrgidis, Anthony J Dixon, Michael Sladden, et al.
Clinical and Experimental Dermatology|October 9, 2025
A multicentre cohort study of the clinicopathological features and treatment outcomes of fibrosing alopecia in a pattern distributionGia Toan Tang, Daranporn Triwongwaranat, Marcelo de Souza Teixeira, et al.
The British Journal of Dermatology|June 22, 2022
Multicentre Selective Lymphadenectomy Trial 1: key primary data remain unavailableAnthony Dixon, Athanassios Kyrgidis, Christopher Zachary, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 3, 2024
Sentinel lymph node biopsy is unreliable in predicting melanoma mortality for both younger and older patientsAnthony J Dixon, Athanassios Kyrgidis, Howard K Steinman, et al.
Geroscience|February 21, 2025
International Consortium to Classify Ageing-related Pathologies (ICCARP) senescence definitions: achieving international consensusEmma Short, Robert T R Huckstepp, Kambiz Alavian, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Defining an Ageing-Related Pathology, Disease or Syndrome: International Consensus StatementEmma Short, Ian M Adcock, Bilal Al-Sarireh, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 31, 2024
BAUSSS biomarker improves melanoma survival risk assessmentAnthony J Dixon, Howard K Steinman, Alexander Nirenberg, et al.
Journal of Clinical Medicine|March 28, 2024
Primary Cutaneous Melanoma-Management in 2024Anthony Joseph Dixon, Michael Sladden, Christos C Zouboulis, et al.
Journal of Clinical Medicine|January 11, 2025
Reply to Pennington, T.E.; Thompson, J.F. Sentinel Node Biopsy in Melanoma Remains a Valuable Clinical Tool. Comment on "Dixon et al. Primary Cutaneous Melanoma-Management in 2024. <i>J. Clin. Med.</i> 2024, <i>13</i>, 1607"Anthony Joseph Dixon, Michael Sladden, Christos C Zouboulis, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 20, 2024
BAUSSS biomarker further validated as a key risk staging tool for patients with primary melanomaAnthony J Dixon, Athanassios Kyrgidis, Michael Sladden, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 23, 2024
Sentinel lymph node biopsy may no longer be a critical component of melanoma managementAthanassios Kyrgidis, Anthony J Dixon, Michael Sladden, et al.
Clinical and Experimental Dermatology|October 9, 2025
A multicentre cohort study of the clinicopathological features and treatment outcomes of fibrosing alopecia in a pattern distributionGia Toan Tang, Daranporn Triwongwaranat, Marcelo de Souza Teixeira, et al.
The British Journal of Dermatology|June 22, 2022
Multicentre Selective Lymphadenectomy Trial 1: key primary data remain unavailableAnthony Dixon, Athanassios Kyrgidis, Christopher Zachary, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 3, 2024
Sentinel lymph node biopsy is unreliable in predicting melanoma mortality for both younger and older patientsAnthony J Dixon, Athanassios Kyrgidis, Howard K Steinman, et al.
Geroscience|February 21, 2025
International Consortium to Classify Ageing-related Pathologies (ICCARP) senescence definitions: achieving international consensusEmma Short, Robert T R Huckstepp, Kambiz Alavian, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Defining an Ageing-Related Pathology, Disease or Syndrome: International Consensus StatementEmma Short, Ian M Adcock, Bilal Al-Sarireh, et al.
Pageof 3